The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
复制标题
DOI：
10.1136/gut.2005.082909
复制
发表时间：
2006-06-01
期刊：
影响因子：
24.5
通讯作者：
Colombel, J-F
中科院分区：
文献类型：
--
作者：
Satsangi, J.;Silverberg, M. S.;Colombel, J-F
近年来，研究人员重新探讨了炎症性肠病分类中涉及的复杂问题。2003年，一个对疾病亚分类问题感兴趣的研究者工作组成立，目的是总结疾病分类的最新进展，并建立炎症性肠病的综合临床、分子和血清学分类。工作组的成果在2005年蒙特利尔世界胃肠病学大会上报告。在这里，我们强调了蒙特利尔工作组讨论中出现的关键问题以及与临床实践和研究活动的相关性。
In recent years, investigators have readdressed the complex issues involved in the classification of inflammatory bowel diseases. In 2003, a Working Party of investigators with an interest in the issues involved in disease subclassification was formed with the aim of summarising recent developments in disease classification and establishing an integrated clinical, molecular, and serological classification of inflammatory bowel disease. The results of the Working Party were reported at the 2005 Montreal World Congress of Gastroenterology. Here we highlight the key issues that have emerged from discussions of the Montreal Working Party and the relevance to clinical practice and research activities.